Variant GADL1 and response to lithium therapy in bipolar I disorder

C. H. Chen, C. S. Lee, M. T M Lee, W. C. Ouyang, Chiao Chicy Chen, M. Y. Chong, J. Y. Wu, H. K L Tan, Y. C. Lee, L. J. Chuo, N. Y. Chiu, H. Y. Tsang, T. J. Chang, F. W. Lung, C. H. Chiu, C. H. Chang, Y. S. Chen, Y. M. Hou, Cheng Chung Chen, T. J. LaiC. L. Tung, C. Y. Chen, H. Y. Lane, T. P. Su, J. Feng, J. J. Lin, C. J. Chang, P. R. Teng, C. Y. Liu, C. K. Chen, I. C. Liu, J. J. Chen, T. Lu, C. C. Fan, C. K. Wu, C. F. Li, K. H T Wang, L. S H Wu, H. L. Peng, C. P. Chang, L. S. Lu, Y. T. Chen, A. T A Cheng

研究成果: 雜誌貢獻文章同行評審

117 引文 斯高帕斯(Scopus)


BACKGROUND: Lithium has been a first-line choice for maintenance treatment of bipolar disorders to prevent relapse of mania and depression, but many patients do not have a response to lithium treatment. METHODS: We selected subgroups from a sample of 1761 patients of Han Chinese descent with bipolar I disorder who were recruited by the Taiwan Bipolar Consortium. We assessed their response to lithium treatment using the Alda scale and performed a genomewide association study on samples from one subgroup of 294 patients with bipolar I disorder who were receiving lithium treatment. We then tested the single-nucleotide polymorphisms (SNPs) that showed the strongest association with a response to lithium for association in a replication sample of 100 patients and tested them further in a follow-up sample of 24 patients. We sequenced the exons, exon-intron boundaries, and part of the promoter of the gene encoding glutamate decarboxylase-like protein 1 (GADL1) in 94 patients who had a response to lithium and in 94 patients who did not have a response in the genomewide association sample. RESULTS: Two SNPs in high linkage disequilibrium, rs17026688 and rs17026651, that are located in the introns of GADL1 showed the strongest associations in the genomewide association study (P = 5.50×10-37 and P = 2.52×10-37, respectively) and in the replication sample of 100 patients (P = 9.19×10-15 for each SNP). These two SNPs had a sensitivity of 93% for predicting a response to lithium and differentiated between patients with a good response and those with a poor response in the follow-up cohort. Resequencing of GADL1 revealed a novel variant, IVS8+48delG, which lies in intron 8 of the gene, is in complete linkage disequilibrium with rs17026688 and is predicted to affect splicing. CONCLUSIONS: Genetic variations in GADL1 are associated with the response to lithium maintenance treatment for bipolar I disorder in patients of Han Chinese descent.

頁(從 - 到)119-128
期刊New England Journal of Medicine
出版狀態已發佈 - 2014

ASJC Scopus subject areas

  • 醫藥 (全部)


深入研究「Variant GADL1 and response to lithium therapy in bipolar I disorder」主題。共同形成了獨特的指紋。